World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
39254
World Ranking
7644
National Ranking
3982

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Bruce A. Chabner is affiliated with Harvard University in the United States. Their research primarily focuses on the field of Medicine, with a specific emphasis on Oncology. Over their career, they have contributed extensively to topics related to cancer, including economic impacts, genomics, diagnostics, and various cancer treatments.

Their recent publications include:

  • Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition, 2022, Nature Medicine
  • Immune Checkpoint Inhibitors - The Need for Innovation, 2023, New England Journal of Medicine
  • Rising Circulating Tumor DNA As a Molecular Biomarker of Early Disease Progression in Metastatic Breast Cancer, 2020, JCO Precision Oncology
  • The Finding of N-Nitrosodimethylamine in Common Medicines, 2020, The Oncologist
  • Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutations, 2021, Breast Cancer Research and Treatment

The frequent co-authors collaborating with Bruce A. Chabner include:

  • Beverly Moy
  • Aditya Bardia
  • Elyse R. Park
  • Ryan David Nipp
  • Steven J. Isakoff

Major publication venues for their research are:

  • The Oncologist
  • Journal of Clinical Oncology
  • JCO Global Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • Nature Medicine

Bruce A. Chabner's work spans several subfields of medical research such as:

  • Oncology
  • Economics and Econometrics
  • Cancer Research
  • Pulmonary and Respiratory Medicine
  • Neurology

The main research topics addressed in their publications include:

  • Economic and Financial Impacts of Cancer
  • Cancer Genomics and Diagnostics
  • Lung Cancer Treatments and Mutations
  • CNS Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Cervical Cancer and HPV Research
  • Global Cancer Incidence and Screening

Among the recognitions received, Bruce A. Chabner is a member of the Association of American Physicians.

Best Publications

  • Timeline: Chemotherapy and the war on cancer.

    Bruce A. Chabner;Thomas G. Roberts

  • The National Cancer Institute: cancer drug discovery and development program.

    Michael R. Grever;Saul A. Schepartz;Bruce A. Chabner

  • The pharmacology and clinical use of methotrexate

    Jacques Jolivet;Kenneth H. Cowan;Gregory A. Curt;Neil J. Clendeninn

  • Histone Deacetylase Inhibitors in Cancer Therapy

    Andrew A. Lane;Bruce A. Chabner

  • Application of Cell-Free DNA Analysis to Cancer Treatment

    Ryan B. Corcoran;Bruce A. Chabner

  • Advanced diffuse histiocytic lymphoma, a potentially curable disease.

    VincentT. Devita;GeorgeP. Canellos;Bruce Chabner;Philip Schein

  • Cancer Chemotherapy and Biotherapy: Principles and Practice

    Bruce A. Chabner;Dan L. Longo

  • Polyglutamation of methotrexate. Is methotrexate a prodrug

    B A Chabner;C J Allegra;G A Curt;N J Clendeninn

  • The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer.

    P G Johnston;E R Fisher;H E Rockette;B Fisher

  • Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy.

    Richard I. Fisher;Vincent T. DeVITA;Susan M. Hubbard;Dan L. Longo

  • Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate Toxicity

    Ronald G. Stoller;Kenneth R. Hande;Samuel A. Jacobs;Steven A. Rosenberg

  • Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase.

    Edward Chu;David M. Koeller;John L. Casey;James C. Drake

  • Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma.

    Philip S. Schein;Vincent T. DeVITA;Susan Hubbard;Bruce A. Chabner

  • Enhanced inhibition of thymidylate synthase by methotrexate polyglutamates.

    C J Allegra;B A Chabner;J C Drake;R Lutz

  • Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia.

    Werner A. Bleyer;James C. Drake;Bruce A. Chabner

  • Inhibition of phosphoribosylaminoimidazolecarboxamide transformylase by methotrexate and dihydrofolic acid polyglutamates.

    Carmen J. Allegra;James C. Drake;Jacques Jolivet;Bruce A. Chabner

  • Cancer Chemotherapy: Principles and Practice

    Bruce Chabner;Jerry M. Collins

  • Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.

    Lawrence Tamarkin;Michael Cohen;David Roselle;Cheryl Reichert

  • Advanced Ovarian Adenocarcinoma A Prospective Clinical Trial of Melphalan (L-PAM) Versus Combination Chemotherapy

    Robert C. Young;Bruce A. Chabner;Susan P. Hubbard;Richard I. Fisher

  • Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy

    Wyndham H. Wilson;Michael L. Grossbard;Stefania Pittaluga;Diane Cole

Frequent Co-Authors

Thomas J. Lynch
Thomas J. Lynch Johns Hopkins University
George P. Canellos
George P. Canellos Harvard University
Vincent T. DeVita
Vincent T. DeVita Yale University
Carmen J. Allegra
Carmen J. Allegra University of Florida
Charles E. Myers
Charles E. Myers University of Virginia
Robert C. Young
Robert C. Young Cornell University
Wyndham H. Wilson
Wyndham H. Wilson National Institutes of Health
Jeffrey W. Clark
Jeffrey W. Clark Harvard University
Dan L. Longo
Dan L. Longo Harvard University
Marc E. Lippman
Marc E. Lippman National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA offers a wealth of flexible online pathways for aspiring and current healthcare professionals. For registered nurses looking to boost their credentials, several rn to bsn without clinicals options allow advancement without the need for additional in-person clinical hours, making it easier to balance work and study.

For those pursuing advanced nursing leadership, there are short dnp programs and dnp programs online designed for efficiency and accessibility. These programs can often be completed at a faster pace, meaning you enter advanced practice roles sooner.

If you're seeking entry into nursing, a 6 month lpn program online provides a streamlined route to licensure. Whether you’re just starting out or advancing your education, online degrees offer flexibility and a variety of career tracks—helping you meet your professional goals in medicine on your terms.

Best Scientists Citing Bruce A. Chabner

Trending Scientists

Recently Published Articles